Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.11 USD | +7.76% | +16.13% | +57.32% |
May. 14 | Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target | MT |
Apr. 12 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.32% | 887M | |
+7.63% | 111B | |
+11.32% | 106B | |
-12.35% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.69% | 16.81B | |
+38.54% | 12.54B | |
-24.35% | 8.09B |
- Stock Market
- Equities
- NRIX Stock
- News Nurix Therapeutics, Inc.
- HC Wainwright Cuts Nurix Therapeutics Price Target to $19 From $35, Maintains Buy Rating